Complete secondary botulinum toxin therapy failure in blepharospasm.
Dressler
D
D
D018726:Anti-Dyskinesia Agents / Q000276:immunology* / Q000627:therapeutic use*; D000917:Antibody Formation; D001764:Blepharospasm / Q000188:drug therapy*; D001905:Botulinum Toxins / Q000276:immunology* / Q000627:therapeutic use*; D018450:Disease Progression; D005260:Female; D006801:Humans; D008875:Middle Aged; D016896:Treatment Outcome
D018726:Anti-Dyskinesia Agents; D001905:Botulinum Toxins